SCHEMBL6880481

SCHEMBL6880481

CSc1ncnc2nc([C@@H]3O[C@H](CO)[C@H](OS(C)(=O)=O)[C@H]3O)[nH]c12

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GMNN O75496 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
BLM P54132 1/20 0.34
PMP22 Q01453 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34
NFKB1 P19838 1/20 0.34
STAT6 P42226 1/20 0.34
HIF1A Q16665 1/20 0.34
TP53 P04637 2/20 0.32
ADK P55263 1/20 0.31
PYGL P06737 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6886930 0.87 KDM4E (0.38) SMN1; SMN2KDM4EGMNNLMNAMAPT
SCHEMBL6885470 0.86 KDM4E (0.32) SMN1; SMN2KDM4EGMNNLMNAMAPT
SCHEMBL6889023 0.77 LMNA (0.36) SMN1; SMN2KDM4EGMNNLMNAMAPT
SCHEMBL6886952 0.72 ACHE (0.33) SMN1; SMN2KDM4EGMNNLMNAMAPT
SCHEMBL6887365 0.72 TP53 (0.35) SMN1; SMN2TP53HSD17B10
SCHEMBL6881897 0.71 ALDH1A1 (0.32)
SCHEMBL6945387 0.71 ADORA2A (0.35) SMN1; SMN2TP53ADKHSD17B10
SCHEMBL11442293 0.69 KDM4E (0.47) SMN1; SMN2KDM4EGMNNLMNAMAPT
SCHEMBL6887345 0.69 KDM4E (0.45) SMN1; SMN2KDM4EGMNNLMNAMAPT
SCHEMBL6880484 0.69 TP53 (0.64) SMN1; SMN2STAT6TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1411954-A2 MODIFIED NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS AND ABNORMAL CELLULAR PROLIFERATION Pharmasset Limited (BB) 2004-04-28 EP disclosed
WO-2002032920-A2 MODIFIED NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS AND ABNORMAL CELLULAR PROLIFERATION PHARMASSET LIMITED (BB) 2002-04-25 WO disclosed